Skip to main content
[Preprint]. 2023 Nov 1:2023.10.27.564454. [Version 1] doi: 10.1101/2023.10.27.564454

Table 1.

Patients and healthy controls.

Healthy controls Patients
Number of individuals 17 28
Female 9 (53%) 12 (43%)
Median age 67 65
Subtype
  GCB DLBCL 13 (46.4%)
  Non-GCB DLBCL 11 (39.3%)
  Other 4 (14.3%)
Stage
  Stage I 3 (10.7%)
  Stage II 7 (25%)
  Stage III 3 (10.7%)
  Stage IV 15 (53.6%)